Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Pays Idaho Tech $3.5M to Settle PCR Patent Suit, Pens Cross-Licensing Pact

NEW YORK (GenomeWeb News) — Cepheid has paid Idaho Technology $3.5 million and penned a cross-licensing agreement to settle a patent-infringement suit, Cepheid said today.
Terms of the settlement call for the companies to pay license fees and enable them to “continue to make and sell their respective lines for products.
Idaho Technology sued Cephied in 2005 for allegedly infringing three patents that cover "rapid polymerase chain reaction methods and instrumentation, use of SYBR Green I in PCR reactions, and certain methods of analysis of real-time PCR data,” Cepheid said.
Cepheid said the settlement “resolves all claims” made by Idaho Tech and its licensor, University of Utah Research Foundation, and resulted in a dismissal of the case.
Idaho Technology, based in Salt Lake City, makes instruments for pathogen detection, reagents, and thermocyclers.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.